Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Perrigo
(NY:
PRGO
)
26.36
-0.57 (-2.12%)
Official Closing Price
Updated: 7:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Perrigo
< Previous
1
2
3
4
Next >
$4.5M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
May 26, 2023
Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Perrigo Q1 Earnings Beat Estimates On Strategic Pricing, CEO Plans Retirement
May 09, 2023
Via
Benzinga
FDA Raises Concerns Regarding Perrigo's OTC Birth Control Pill, Casts Doubts Over Real-World Use
May 08, 2023
The FDA's Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) will be meeting this week to review Perrigo Company...
Via
Benzinga
FDA Sets New Adcomm Date To Review Perrigo's Oral Contraceptive Pill For OTC Use
March 28, 2023
Via
Benzinga
Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage
March 21, 2023
House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year.
Via
Benzinga
Insiders Selling Perrigo And 3 Other Stocks
March 10, 2023
The Nasdaq Composite dropped by around 2% on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Earnings Outlook For Perrigo Co
February 24, 2023
Via
Benzinga
Why Perrigo Stock Tanked on Tuesday
November 08, 2022
A double miss and a guidance cut badly affected investor sentiment.
Via
The Motley Fool
FDA Postpones Review Meeting For First OTC Contraceptive Option From Perrigo
October 26, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
7 Perfect Presents to Gift Your 2023 Stock Portfolio
December 21, 2022
As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023.
Via
InvestorPlace
SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON
December 16, 2022
Stolkholm’s Best Kept Skincare Secret Is The Perfect Gift For Giving
From
ACO
Via
GlobeNewswire
Perrigo Shares Pop On Raised FY22 Guidance Surpassing Consensus Estimates
May 11, 2022
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Via
Benzinga
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday
November 08, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance
November 08, 2022
Via
Benzinga
FDA Schedules AdComm Review For First Over The Counter Birth Control Pill
September 13, 2022
Via
Benzinga
Is Sanofi A Buy, Despite Recent Stumbles?
August 19, 2022
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim
July 12, 2022
Institutional investors like mutual funds can't get enough of Perrigo stock. It has an A Accumulation/Distribution Rating.
Via
Investor's Business Daily
Perrigo Seeks FDA Approval For the First OTC Contraceptive Pill
July 11, 2022
Perrigo Company plc's (NYSE: PRGO) HRA Pharma has
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
September 06, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
July 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For August 9, 2022
August 09, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Via
Benzinga
This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives
June 27, 2022
The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical...
Via
Benzinga
Bette Midler Panned For Breastfeeding Remark In Wake Of Baby Formula Shortage
May 16, 2022
Singer and actress Bette Midler received a round of boos on Twitter Inc (NYSE: TWTR) after volunteering the idea that American women impacted by the ongoing baby formula shortage turn to...
Via
Benzinga
Cannabis Movers & Shakers: MedMen's New CEO, TerrAscend, FoliuMed, Charlotte's Web & Proof Announce Appointments
April 29, 2022
MedMen Names New CEO Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed a new CEO, Edward Record, who has been serving on the company's board since 2021.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.